Daily Stock List
Authentidate Holding Corp. (ADAT)
Profit Confidential reported recently on Authentidate Holding Corp. (ADAT), HotOTC, CoolPennyStocks, StockRich, BullRally, MadPennyStocks, StockEgg, PennyStockVille, PennyInvest, SmarTrend Newsletters, Wall Street Resources did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Authentidate Holding Corp. is a provider of secure web-based software applications and telehealth products and services. These enable healthcare organizations to coordinate care for patients and enhance related administrative and clinical workflows. Their healthcare customers and users include leading homecare companies, health systems, physician groups and governmental entities.
The Company's products and services enable healthcare organizations to increase revenues, reduce costs and enhance patient care by eliminating paper and manual work steps from clinical and administrative processes. Authentidate's shares trade on the NASDAQ Capital Market. The Company has their corporate headquarters in Berkeley Heights, New Jersey.
Authentidate's telehealth solutions combine Electronic House Call; an FDA 510(k) cleared in-home patient vital signs monitoring system, or the Interactive Voice Response system with a web application that streamlines patient monitoring. Delivered as Software as a Service (SaaS), customers only require an Internet connection and web browser to access the Company's web-based applications.
The Company's care coordination solutions ensure that patients stay healthy, stick to their care plans, and avoid costly hospital re-admissions and ER visits. Authentidate is the first company to provide an end-to-end solution that enables the healthcare industry to manage patients in post-acute care as they are in more structured settings such as hospitals. The result is the ability to better track patient progress, and intervene when necessary to ensure that patients are getting better.
Recently, Authentidate announced financial results for the three and nine-month periods ended March 31, 2012. Revenues for the quarter ended March 31, 2012 were approximately $764,000 compared to $729,000 for the prior year period. Net loss from continuing and discontinued operations for the quarter ended March 31, 2012 was $2,018,000, or $0.04 per share, compared to $1,621,000, or $0.04 per share, for the prior year period.
Revenues for the nine months ended March 31, 2012 were approximately $2,176,000 compared to $2,157,000 for the prior year period. Net loss for the nine months ended March 31, 2012 was approximately $5,597,000, or $0.12 per share, compared to $10,493,000, or $0.25 per share, for the prior year period.
Authentidate Holding Corp. (ADAT), closed Thursday's trading session at $0.65, down 1.52%, on 76,733 volume with 118 trades. The average volume for the last 60 days is 53,250. The 52-week low/high is $0.55/$1.29.
Graymark Healthcare, Inc. (GRMH)
OTCPicks reported recently on Graymark Healthcare, Inc. (GRMH), SmallCap Voice, Daily Markets, PennyOmega did previously, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Graymark Healthcare, Inc. is the nation's second largest provider of sleep management solutions. The Company diagnoses and treats more than 80 sleep disorders. Graymark also specializes in comprehensive care for Obstructive Sleep Apnea (OSA). The Company also sells equipment and related supplies and components used to treat sleep disorders. Graymark Healthcare has their headquarters in Oklahoma City, Oklahoma.
The Company offers their services through 105 sleep laboratories primarily in the Midwest. These include standalone or IDTF facilities, therapy facilities, rural outreach hospital sites and urban hospital management agreements.
In May, Graymark Healthcare announced that the Company signed a non-binding letter of intent to combine with Foundation Surgery Affiliates, LLC and Foundation Surgical Hospital Affiliates, LLC, together known as Foundation Healthcare, in an all-stock transaction valued at $1.10 per common share. The aggregate transaction value is approximately $52.5 million.
At closing, Graymark Healthcare will issue a combination of common stock and preferred stock to Foundation, and a separate series of preferred stock with a stated value of approximately $14 million. Additionally, Graymark will issue warrants covering 4 million shares of their common stock exercisable at $1.50 per share. The intention of this is to reward Foundation to the extent that there is shareholder value driven by a substantial increase in the share price from current levels. Graymark Healthcare would be the surviving entity name upon the closing of the transaction, which is expected in the third quarter of 2012.
In addition, last month, the Company reported financial results for the first quarter ended March 31, 2012. Net revenues in the first quarter of 2012 increased 4 percent to $4.4 million, compared to $4.2 million in the first quarter of 2011 (as adjusted for the sale of Nocturna East Sleep Centers). Loss from continuing operations, net of taxes, in the first quarter of 2012 was $1.9 million, compared to a loss of $1.8 million in the year-ago quarter. Net loss attributable to Graymark was $1.9 million or $(0.13) per share in the first quarter of 2012, compared to a net loss of $1.8 million or $(0.25) per share in the year-ago quarter.
Graymark Healthcare, Inc. (GRMH), closed Thursday's trading session at $0.38, up 17.98%, on 12,232 volume with 23 trades. The average volume for the last 60 days is 23,947. The 52-week low/high is $0.28/$1.39.
Torchlight Energy Resources, Inc. (TRCH)
500PCT reported earlier on Torchlight Energy Resources, Inc. (TRCH), Stockpalooza did previously, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Torchlight Energy Resources, Inc. is a junior oil and gas player with a primary spotlight on oil. The Company will focus on highly probable and profitable drilling and working interest programs that have a short window of payback, a high IRR, proven and bookable reserves, and are United States based. They will partner with operators, or purchase working interest ownerships in proven development focused fields. They will also identify solid, highly probable drilling opportunities. Torchlight Energy is based in Houston, Texas.
The Company's projects include Marcelina Creek – Wilson County, Texas. Bayshore Operating and Torchlight have executed an agreement for Torchlight to re-enter 1 well and drill 3 vertical wells on the 1045-acre lease block. The Johnson #1 has been drilled and encountered good oil and gas shows and extensive fracturing. Approximately 25 BOPD is being produced currently.
The agreement also requires a cash payment of $750k for all surface equipment, lease cost and geological investigation. Once the re-try and 3 wells are drilled Torchlight will have earned a 50 percent interest in the Johnson and a 75 percent interest in the remaining acreage in the lease. More than 7 locations remain to be drilled.
Torchlight also has their Fossil Energy, Southwestern Nebraska – Exploitation Drilling Program. Fossil Energy and Torchlight have executed an agreement to begin work on identifying and possibly funding up to a 50 well drilling program. The locations will be based on technologies incorporated in the oil industry. Torchlight would fund the drilling of the wells and receive 75 percent of the net revenue.
Today, Torchlight Energy Resources issued an update on the Johnson #1 in Marcelina Creek. As previously announced, the Johnson #1-H was damaged during a work over by a service company. Torchlight has been in discussions with the service company and has recently received their commitment letter to re-enter the wellbore and re-drill and complete the approximate 1800' horizontal leg in the Buda formation at their sole expense.
Torchlight Energy Resources, Inc. (TRCH), closed Thursday at $1.50, up 20.00%, on 3,900 volume with 5 trades. The average volume for the last 60 days is 3,414. The 52-week low/high is $0.73/$3.90.
Jaxon Minerals, Inc. (JAX.V)
Today we are highlighting Jaxon Minerals, Inc. (JAX.V), here at the QualityStocks Daily Newsletter.
Jaxon Minerals, Inc. is an exploration stage company that engages in the acquisition, exploration, and development of mineral properties. The Company has entered into Option Agreements that allow it to acquire 100 percent of the mineral rights to three properties located in the Flin Flon-Snow Lake volcanogenic massive sulphide (VMS) and gold deposit Greenstone Belt in Manitoba and Saskatchewan. Jaxon Minerals lists on the TSX Venture Exchange. The Company has their headquarters in Vancouver, British Columbia.
The Company's properties are strategically located and comprise the Lucile Lake Block, (3,976 hectares) and, the Snow Lake Block, (144 hectares) in central Manitoba and the Beatty Lake Block, (440 hectares) in Saskatchewan. The claims are easily accessible by road, winter trails and railway infrastructure, which serve both the Flin Flon and Snow Lake communities.
The Lucile Lake Block is 20 kilometers east of Flin Flon. This property contains Amisk Group rocks known in the Flin Flon-Snow Lake Volcanic Belt to host major base and precious metal deposits. The Lucile Lake copper prospect has Copper, Gold and Silver grades typical of the belt. The 2011 airborne geophysical survey shows anomalous trends across the property.
The Snow Lake Block is located strategically southeast of the Reed Lake VMS discovery. Airborne geophysical surveys indicate EM-magnetic anomaly trends. The correlation is generally considered to be caused by sulphides (pyrrhotite) magnetite.
The Beatty Lake Block is 15 kilometers west of Flin Flon. Surface mineralized samples contain economic grades of Cu, Au, Ag and Zn typical of VMS deposits in the belt. Airborne geophysical surveys completed in November 2011 indicate VTEM-Magnetic anomalous trends generally considered to correlate with buried sulphides. Detailed modeling of the geophysical data indicates several 2012 drill-ready targets.
In April, Jaxon Minerals announced that Mr. Paul Zdebiak accepted the position of President and Director of the Company effective April 2, 2012. Mr. Zdebiak has been involved in the financial industry since 1980, including being a registered investment advisor for 14 years with three full service investment firms. He has been a director and officer of various public companies since 2002. He brings a broad spectrum of experience in the mining industry to Jaxon Minerals.
Jaxon Minerals, Inc. (JAX.V), closed Thursday's trading session at $0.08, even with yesterday’s close. The 52-week low/high is $0.07/$0.19.
Sierra Resource Group, Inc. (SIRG)
OTCPicks reported last week on Sierra Resource Group, Inc. (SIRG), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Trading on the OTCBB, Sierra Resource Group, Inc. is an exploration and mining company. Their commitment is to the exploration, discovery and development of gold, silver, copper and other mineral resources. The Company's primary asset is 80 percent ownership of the Chloride Copper Mine located near Kingman, Arizona. The main effort of Sierra Resource is to acquire the necessary funding to bring the Chloride Copper Mine into production in order to generate working capital from their operation. They will also continue their strategy to acquire other mining prospects as well as further development of the Chloride Copper Mine.
The Chloride Copper Mine property consists of 37 unpatented lode mining claims and 12 mill site claims. It is 24km northwest of Kingman, in the Wallapai District, Mohave County, Arizona. The Chloride Copper Mine consists of an open pit mine and the existing onsite SXEW (Solvent extraction/electrowinning) processing plant. Effective February 20, 2012, Sierra Resource's Board of Directors approved the purchase of half of the minority interest in the Chloride Copper Mine from the Medina Property Group, LLC under the terms of a Letter Of Intent. The execution of this transaction would increase the Company's interests in the Chloride Copper Mine to 90 percent.
As of November 2011, Sierra Resource had received initial assay results from their Chloride Copper Mine (AKA Emerald Isle Mine) drill program on the tailings impoundment at their Chloride Copper Mine Property near the town of Chloride, in Mohave County, Arizona. Copper grades ranged from a minimum of 0.16 percent Cu to a maximum of 0.43 percent Cu with the average being 0.36 percent Cu. The report also estimated the tailings to contain approximately 1.2 million tons of material.
The objectives of this drill program were designed to collect material to confirm the grade of copper mineralization that was previously reported by SGV Resources Inc. Sierra Resource informs that copper distribution appears to be consistent over all the samples collected from the tailings impoundment. The tailings are the waste product from the previous operation of the Emerald Isle Mine from 1943 to 1973 when copper recovery was much lower than recovery rates available with today's technology.
Sierra Resource Group, Inc. (SIRG), closed Thursday's trading at $0.0095, up 33.80%, on 2,056,411 volume with 38 trades. The average volume for the last 60 days is 2,627,433. The 52-week low/high is $0.0008/$0.019.
Finavera Wind Energy, Inc. (FVR.V)
Investor Ideas and Green Chip Stocks reported previously on Finavera Wind Energy, Inc. (FVR.V), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Founded in Dublin, Ireland in 2003, Finavera Wind Energy, Inc. is a wind energy development company whose shares trade on the TSX Venture Exchange. The Company focuses on developing, constructing, and operating wind farms in North America and Ireland. Their mission is to create and operate a viable renewable energy business while protecting and enhancing the physical and social environment. Finavera Wind Energy is based in Vancouver, British Columbia.
In British Columbia, projects totaling 301 MW have been awarded 25 year Electricity Purchase Agreements. In Ireland, Finavera has signed a co-development agreement with Scottish and Southern Renewables for the 105MW Cloosh Valley Wind Project. Data collection and environmental studies have been continuing at a number of prospective sites in Canada and the U.S.
The Company has focused their Canadian wind activities in the Peace region of British Columbia. All areas have a historically strong wind resource. This makes them extremely attractive for wind development. Environmental consultants have been engaged to lead the projects through the provincial Environmental Assessment process. With four energy projects in British Columbia, the Company will be generating 301 megawatts of clean energy - enough to power 75,000 households -by program completion in 2015.
In Ireland, in the province of Connacht, Finavera's project site is 25km northwest of Galway City. Resource assessments identified wind speeds of 8.9 meters per second. Finavera focuses on identifying areas for early-stage wind project development to enhance their long-term wind project pipeline.
In late March 2012, Finavera Wind Energy announced that their 49.6 megawatt (MW) Tumbler Ridge Wind Energy Project received an Environmental Assessment Certificate (EAC). B.C. Minister of the Environment Terry Lake and Minister of Energy and Mines Rich Coleman made the decision to grant the EAC after considering the review led by B.C.'s Environmental Assessment Office (EAO). The $125-million project will be located 8 kilometers west of Tumbler Ridge. Upon completion, the project will generate enough power to provide electricity for up to 18,000 homes.
Earlier this month, Finavera Wind Energy announced that they arranged an $850,000 bridge loan. The loan has a one-year term with an annual interest rate of 7 percent. A total of 2,000,000 share purchase warrants will be issued to the lender, with each warrant exercisable at $0.18 for 12 months from the date of closing of the loan. Proceeds of the loan will be primarily used for general working capital and ongoing wind project development. This bridge financing will provide Finavera with sufficient working capital to progress to a strategic transaction.
Finavera Wind Energy, Inc. (FVR.V), closed Thursday's trading session at $0.17, down 2.94%, on 26,554 volume. The 52-week low/high is $0.13/$0.64.
SinoHub, Inc. (SIHI)
SmarTrend Newsletters, HotOTC, StockRich, CoolPennyStocks, PennyStockVille, BullRally, and StockEgg reported earlier on SinoHub, Inc. (SIHI), and we highlight the Company, here at the QualityStocks Daily Newsletter.
SinoHub, Inc. is an electronics company with headquarters in Shenzhen, China. The Company services clients worldwide. SinoHub currently engages in two business segments. These are electronics product manufacturing and sales (ICM, Integrated Contract Manufacturing), and electronic component sales and services (ECSS) comprised of electronic component sales (known as ECP) and electronic component supply chain management services (known as SCM). SinoHub reports on each of ICM and ECSS as separate business segments.
Their ICM business unit is currently focusing on providing custom, private label mobile phones to customers in developing countries. This fast growing ICM segment is capitalizing on a trend by carriers and distributors to offer their own brands with features and functionality targeted at their local markets. This includes 3G smart phones, at competitive prices.
SinoHub's ECSS business unit provides procurement-fulfillment, spot component sales and supply chain management (SCM) services to manufacturers and design houses. The Company's SCM services include warehousing, delivery, import/export, and give their customers complete transparency into their supply chains through delivering SinoHub SCM. This is a proprietary, Web-based software platform the Company has been using for nearly ten years.
In May, SinoHub announced their unaudited financial results for the first quarter ended March 31, 2012. Total net sales increased 62.7 percent year-over-year to US$61.8 million in the first quarter of 2012 compared to US$38.0 million in the first quarter of 2011. Gross profit was US$1.6 million compared to US$7.7 million in the same quarter in 2011. Gross margin was 2.6 percent compared to 20.3 percent in the first quarter of 2011.
Cash provided by operations was US$1.8 million, compared with US$4.4 million in the first quarter of 2011. The Company had a net loss of US$2.2 million in the first quarter of 2012, compared to net income of US$3.5 million in the first quarter of 2011. Net loss per basic and diluted share were both US$0.07, compared to net income of US$0.12 per basic and diluted share, in the first quarter of 2011.
Commenting on the results, SinoHub's CEO, Mr. Harry Cochran, said, "Our results for the quarter demonstrate both the continuing challenges that we face following the loss of our largest ICM customer in the second quarter of 2011 and the progress that we have made in the strategic repositioning of SinoHub as a custom mobile device manufacturer operating on a global basis."
SinoHub, Inc. (SIHI), closed Thursday at $0.29, down 3.33%, on 700 volume with 4 trades. The average volume for the last 60 days is 64,261. The 52-week low/high is $0.22/$1.48.
DURECT Corp. (DRRX)
Wall Street Resources reported recently on Comprehensive Care Corp. (CHCR), BullRally, StockRich, HotOTC, CoolPennyStocks, MadPennyStocks, PennyStockVille, PennyInvest did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 1998, DURECT Corp. focuses on the development of pharmaceutical products for pain, central nervous system disorders, cardiovascular disease, and other chronic diseases. They do this based on their proprietary drug formulations and delivery platform technologies. DURECT is employing advanced enabling drug delivery technologies to develop new and improved pharmaceutical products. The Company's mission is to develop therapies that will improve the quality of life for patients with chronic diseases and other medical conditions. DURECT has their corporate headquarters in Cupertino, California.
The Company's platform technologies include the SABER™ Delivery System. This is a patented and versatile depot injectable useful for proteins, peptides and small molecule delivery.The SABER™ Delivery System is a patented controlled-release technology that can be formulated for systemic or local administration of active agents by way of the parenteral or oral route. The Company is researching and developing a variety of controlled-release products based on the SABER technology.
DURECT's products include Remoxy, an oxycodone gelatin capsule for chronic pain, which has acceptance as a new drug application, and POSIDUR, a release formulation of bupivacaine that is under a Phase III clinical trial for postoperative pain. Their products also include ELADUR, a transdermal bupivacaine patch, which is under a Phase II clinical trial. It provides continuous delivery of bupivacaine for up to three days from a single application. It is also for the treatment of pain associated with post-herpetic neuralgia.
Their products also include TRANSDUR-Sufentanil, a proprietary transdermal sufentanil patch, which is under a Phase II clinical trial. It provides continuous delivery of sufentanil for a period of up to seven days from a single application. DURECT's products also consist of an oral controlled release opioid for pain that is under a Phase I clinical trial, and ORADUR-ADHD, a preclinical trial product targeting attention deficit hyperactivity disorder.
The Company markets ALZET, miniature implantable osmotic pumps and accessories for experimental research in mice, rats, and other laboratory animals. Furthermore, they develop and manufacture different biodegradable polymers based on lactide, glycolide, and caprolactone under the LACTEL brand for pharmaceutical and medical device clients. Additionally, they conduct research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies.
In July 2011, DURECT signed a development and license agreement with Zogenix to develop Relday™ (Risperidone Program), a product candidate targeting the antipsychotic market. Zogenix expects to initiate clinical studies for Relday in patients with schizophrenia this year. Relday is a proprietary, long-acting (once-monthly) injectable formulation of 0.5 mL of risperidone using DURECT's SABER controlled-release formulation technology in combination with Zogenix's DosePro® needle-free, subcutaneous drug delivery system.
DURECT Corp. (DRRX), closed Thursday's session at $0.82, up 0.02%, on 471,864 volume with 1,799 trades. The average volume for the last 60 days is 315,045. The 52-week low/high is $0.68/$3.10.
FluoroPharma Medical, Inc. (FPMI)
The QualityStocks Daily Newsletter would like to spotlight FluoroPharma Medical, Inc. (FPMI). Today, FluoroPharma Medical, Inc. closed trading at $0.80, even with yesterday's close, on 5,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 18,821, and its 52-week low/high is $0.56/$2.15.
FluoroPharma Medical, Inc. (FPMI) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.
The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.
By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.
The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer
FluoroPharma Medical, Inc. Company Blog
FluoroPharma Medical, Inc. News:
FluoroPharma CEO Provides Shareholders With a "State of the Union" Communication
LifeTech Capital Initiates Coverage of FluoroPharma Medical, Inc.
FluoroPharma is Granted Patent Rights for BFPET in Australia, Expanding Global Patent Position
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.60, off by 0.62%, on 6,300 volume with 10 trades. The stock’s average daily volume over the past 60 days is 6,255, and its 52-week low/high is $1.02/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise to Present at the Inaugural Marcum MicroCap Conference on June 20th in New York City
GlobalWise Signs Channel Sales Partnership With Sycle.net
GlobalWise Announces Success of Partner Advisory Board Event
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.38, off by 7.32%, on 105,954 volume with 38 trades. The stock’s average daily volume over the past 60 days is 202,141, and its 52-week low/high is $0.21/$1.15.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Scientists Create New Protein-Based Stem Cell Technology
International Stem Cell Corporation Announces Marketing Plans for Its Wholly Owned Subsidiary Lifeline Skin Care
International Stem Cell Corp Announces First Quarter 2012 Financial Results and Business Highlights
SilverSun Technologies, Inc. (SSNT)
The QualityStocks Daily Newsletter would like to spotlight SilverSun Technologies, Inc. (SSNT). Today, SilverSun Technologies, Inc. closed trading at $0.27, off by 6.90%, on 1,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 21,399, and its 52-week low/high is $0.005/$0.51.
SilverSun Technologies, Inc. (SSNT), via wholly-owned subsidiary SWK Technologies, is a premier total solutions provider specializing in business software for manufacturers and distributors. Established in 1988, the company focuses on meeting the needs of small-sized and mid-sized businesses ("SMB" marketplace) with accounting and business management products, including SilverSun's own proprietary software. The company also offers its own cloud-based solutions and provides network services (network configuration, data backup, 24/7 remote monitoring, etc.) to its clients.
SilverSun distinguishes itself from traditional software resellers by offering a wide range of value-added services, consisting primarily of programming, training, technical support, and other consulting and professional services. The company also provides software customization, data migration, business consulting, and implementation assistance for complex design environments. Currently, the company has over 1,000 active customers.
In addition to driving organic growth, SilverSun's aggressive growth strategy includes acquiring firms in the extensive and expanding SMB marketplace to create substantial value for its shareholders, employees, and partners. SilverSun aims to leverage SWK Technologies as a platform to roll up and aggregate the best and brightest ERP resellers, as well as other software companies with proprietary products that serve the SMB marketplace. The company's most recent acquisition was in January 2012.
In 2011, SilverSun increased sales 40% over the previous year and strengthened its balance sheet through the elimination of all outstanding debt. With organic sales accelerating, significant debt reduction, and great depth of expertise and resources, SilverSun is well positioned to become a dominant player in the growing business software marketplace. Disclaimer
SilverSun Technologies, Inc. Blog
SilverSun Technologies, Inc. News:
SilverSun Technologies Completes Asset Purchase of Chicago-Based Hightower
SilverSun Technologies Completes Asset Purchase of Micro-Point
SilverSun Technologies Reports First Quarter 2012 Results
GlobalWise subsidiary Intellinetics, in conjunction with Samsung, provides Intellivue XOA, a platform that combines Samsung’s XOA (eXtensible Open Architecture) printer and copier devices with Intellivue’s powerful ECM (Enterprise Content Management) platform.
Intellivue is a unique cloud-based ECM (Enterprise Content Management) solution for businesses that allows clients to access and manage the contents of all types of documents from virtually any computer or smartphone, from anywhere in the world. Intellivue XOA represents a new level of functionality in workflow, indexing, security, and enhanced document access and control. It provides an exceptionally easy to implement and cost effective solution to document management, allowing any business to rapidly search and access digitized information across large numbers of documents. Integration with the Samsung XOA platform lets users make full use of Samsung’s multifunction printers and copiers.
The new GlobalWise offering comes from the company’s move away from a direct a marketing approach to a more channel based strategy, working with Samsung and various other vendor partners, in addition to using value-added resellers and IT providers, primarily targeting the small to medium business (SMB) market. Intellinetics offers software products, such as Intellivue, based upon open architecture, compatible with all major operating systems. The software is Open Database Compliant (ODBC) for easy integration into any existing database environment. Intellinetics’ software uses an innovative mass-storage algorithm to compress stored information so that files matching search specifications can be retrieved in sub-second time, regardless of the number of files, the size of the network, or the number of simultaneous users. The result is a solution that lowers costs, improves efficiencies, and encourages people to think and work in new ways.
For additional information on GlobalWise Investments, visit the company’s website at www.GlobalWiseInvestments.com
Parthenogenesis is a term that comes from the Greek word for virgin, parthenos, and genesis, from the Greek word gignesthai, meaning to be born. It’s a good descriptive name for the powerful new stem cell technology developed by International Stem Cell Corporation.
Unlike embryonic stem cells, generated from early stage embryos, parthenogenesis utilizes unfertilized human eggs to create what are called parthenogenetic stem cells (hpSC). By using unfertilized human eggs, the cells inherit a duplicate set of human leukocyte antigen (HLA) genes. This significantly reduces the possibility of the derived cells being rejected by an individual’s immune system, making a single cell line suitable for treating millions of individuals. As a result, these unique parthenogenetic stem cells can be immune-matched to millions of persons of differing sexes and racial backgrounds. A relatively small number of hpSC lines could provide sufficient immune-matched cells to cover large parts of the world’s population.
The goal of ISCO is to use this remarkable new source of stem cells to treat a variety of severe diseases, where cell therapy is of value but where the availability of safe immune-matched human cells is limited.
• Treatment of Parkinson’s – 60,000 cases are diagnosed each year in the U.S. alone, the second most prevalent neurodegenerative disease.
• Treatment of Liver Damage – 30,000 deaths are reported each year, with estimates of yearly direct health care costs for chronic and acute liver disease in the U.S. ranging from $60 billion to over $100 billion.
• Cornea Tissue Implants – There are approximately ten million people in the world who are blind because they have damaged their cornea, representing a large unmet medical need.
In support of their therapeutic programs, ISCO is focused on expanding their bank of parthenogenetic stem cell lines, enrolling egg donors and optimizing their methodology for the creation of additional HLA homozygous lines. UniStemCell bank is the life science industry’s first collection of non-embryonic histocompatible human stem cells available for research and commercial use.
For additional information, visit the company’s website at: www.internationalstemcell.com
Georgetown, which has rapidly established itself as a provider of oilfield services/equipment to a variety of domestic and international clients via wholly-owned operating subsidiary, Synergy Oil Tool & Supply LLC, reported today that the company’s first major sale, totaling some $100k of equipment, has been completed. In addition the company was pleased to announce that 25-year veteran of horizontal directional drilling construction and oilfield tooling industries, Gary Haub, has been appointed President of Synergy.
Haub, who is no stranger to such deals, having cut his teeth as an entrepreneur and Products Manager at portable drilling rig and equipment designer/manufacturer, GEFCO (based in Oklahoma), commented on the awesome job done by GTCP management in securing this major sale.
The full spectrum approach of providing all of the necessary accoutrements contractors need to get the job done makes Synergy a one-stop-shop for “crown to ground” support. Oil and gas development is some of the hardest work on earth and bringing in a complex horizontal well to completion often requires that the suppliers know even more about what is required than the contractors themselves. It is this kind of sweeping, broad expertise Mr. Haub brings to the table as Synergy’s top gun.
CEO of GTCP, Carl Swan, was clearly thrilled to land such a talented and experienced grassroots entrepreneur in the sector like Haub. From establishing noted supplier Drill Tube International back in 1996, which he later served as the VP of Operations, departing some nine years after he took the post, seven years after DTI was acquired by Grant Prideco, to his co-ownership of HDD Rotary afterwards, where he served as President and day-to-day operational overwatch/strategic planning, Mr. Haub has put in the work to earn this appointment.
Haub should serve as a beacon of trust for contractors/operators, driving in even more business.
Swan went on to extol the presence and influence built up by Haub in the Midwest market, noting how this widely shared respect throughout the oil and gas industry will help take the company’s growth strategy to the next level. Swan expressed profound confidence over the extent to which both Haub and the company deeply value the shared principles of hard work, integrity, and social giving.
Energized by the obvious momentum Haub’s appointment as the Presidency of Synergy will bring to operations, Swan projected that the guidance he will provide now allows further organic expansion of the management team and shareholder value. Creating a highly responsive, eminently knowledge, and totally equipped supply chain that customers in the break-neck oil and gas industry can count on is what it’s all about for the company.
Incoming President of Synergy, Gary Haub, was truly grateful for the vote of confidence expressed by GTCP and emphasized how superb it was for the company’s reputation, securing this deal so quickly. For an exploration stage company, GTCP has really hit the ground running here and has already made a name for itself.
For more information on the contract, the appointment of Gary Haub, or to learn more about Synergy Oil Tool & Supply LLC and its parent company, Georgetown Corp., please visit the company’s website at:www.GeorgeTownCorp.net
ATP Oil & Gas announced that it has completed a private placement consisting of a $35 million unsecured convertible note, as well as a warrant to purchase shares of ATP common stock.
The note accrues interest at the rate of 8.0% per year, and matures December 20, 2013. Principal and interest are payable in four quarterly installments. ATP can choose to pay the installments in cash, shares of company’s common stock, or a combination of the two.
The note can be converted at the discretion of the holder, in whole or in part, at any time into shares of ATP’s common stock at the designated initial conversion price of $4.46 per share. Should ATP elect to pay installments in shares of common stock then the conversion price will be set at either the initial conversion price or 87% of the market price of the common stock installment payment date. The price will be set at the lesser of the two values.
The transaction also featured the issue of a warrant to the purchaser exercisable for up to 3,923,767 shares of ATP’s common stock at an initial exercise price of $6.69 per share. If, on the eighteen-month anniversary of the closing date the exercise price of the warrant is greater than the then current market price of the common stock, then, subject to certain conditions, the exercise price will be reset to the market price on that date. The warrant has a term of 5.5 years and may be exercised by the holder in whole or in part at any time after the six-month anniversary of the date of issuance.
ATP intends to use the gross proceeds from the transaction of $35.0 million for working capital.
Please refer to ATP’s Form 8-K filed on June 20, 2012 for a more complete description of the transaction.
KLR Group acted as the exclusive placement agent for the transaction.
For further information, please visit www.atpog.com
Today's Top 3
Investor News Source
The QualityStocks Public Company Sponsor News